- No file added yet -

Use, Persistence, Efficacy and Safety of Apixaban in Patients with Non-Valvular Atrial Fibrillation in Unselected Patients in Germany. Results of the Prospective Apixaban in Atrial Fibrillation (APAF) Registry.

figure

posted on 2020-07-06, 09:42 authored by Uwe Zeymer, Christiane Lober, Andreas Wolf, Frank Richard, Heinrich Schäfer, Jens Taggeselle, Hans-Joachim Kabitz, Roland Prondzinsky, Tim Süselbeck, on behalf of the APAF-Investigators.

The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).